ZTABS builds computer vision systems for Berlin's healthcare and life sciences sector — medical imaging AI for radiology, digital pathology analysis, and diagnostic support systems built to meet EU MDR requirements and integrate with German hospital IT infrastructure.
Berlin is Europe's medical imaging AI capital. The Charité — Universitätsmedizin Berlin is one of the world's largest university hospitals with 3,000+ beds and research groups pushing the frontiers of AI-assisted diagnosis. The Berlin Institute of Health (BIH) bridges Charité research with clinical application. Companies like Aignostics (digital pathology), Vara (mammography AI), and Merantix (AI venture studio spawning healthcare companies) have established Berlin as the primary European hub for medical computer vision. The clinical demand is driven by a German healthcare system under pressure. Germany has 1,900+ hospitals and 14,000+ radiology practices generating millions of medical images daily — CT scans, MRIs, X-rays, mammograms, and histopathology slides. The German Radiological Society reports a growing radiologist shortage: current training capacity cannot replace retiring radiologists, and the imaging volume grows 3-5% annually as clinical guidelines expand screening programs and imaging-guided procedures. A radiologist reviewing 80-120 CT studies per day cannot sustain the concentration needed to detect every subtle finding. Studies consistently show that radiologist accuracy decreases after 4+ hours of continuous reading. A 2mm lung nodule on slice 187 of a 300-slice chest CT is easy to miss at 4:30 PM after 7 hours of reading. Computer vision does not fatigue. It processes every slice, every image, at the same level of attention. The role of AI in radiology is not to replace radiologists but to be a tireless second reader that flags findings the human might miss — and to pre-process studies so the radiologist focuses their expertise on interpretation rather than detection.
Berlin's medical imaging market draws from the city's unique concentration of healthcare, research, and AI talent. Charité processes 1.5+ million outpatient cases and 140,000+ inpatient cases annually — the imaging volume alone generates an immense dataset for AI development (with proper ethical approvals and patient consent). The German healthcare system is well-funded (healthcare spending exceeds €400 billion annually, 12.7% of GDP) and increasingly digital: the Krankenhauszukunftsgesetz (Hospital Future Act, KHZG) allocated €4.3 billion for hospital digitization including AI-assisted diagnostics. Specific imaging AI opportunities: mammography screening (Germany's screening program covers 10+ million women aged 50-69; AI-assisted reading can improve detection rates and reduce recall rates), lung cancer screening (Germany is implementing low-dose CT screening per EU recommendations — radiologist capacity to read these additional studies does not exist without AI support), and digital pathology (pathologist shortage is more severe than radiologist shortage; whole slide image analysis can pre-screen and prioritize cases). Beyond diagnosis, the pharmaceutical industry in Berlin (Bayer's pharmaceutical division, Berlin-Chemie, Pfizer's Berlin site) needs computer vision for drug development: histopathology analysis in preclinical studies, cell counting in assays, and compound screening using image-based readouts. Berlin's strengths: DFKI (German Research Center for AI), Fraunhofer HHI (imaging research), TU Berlin and HU Berlin computer science departments, and a startup ecosystem that has produced 15+ medical AI companies. Regulatory pathway: EU MDR (Medical Device Regulation) provides a clear (if demanding) path to CE marking for AI-based medical devices, and German BfArM (Federal Institute for Drugs and Medical Devices) is one of Europe's most sophisticated regulators for health AI.
Our Berlin medical imaging AI development follows the regulatory-first principle: every project is designed from day one for EU MDR compliance and clinical validation. Software classification under MDR: imaging AI that provides diagnostic support (e.g., "suspicious lesion detected, recommend further investigation") is typically classified as Class IIa medical device software (SaMD). This requires: quality management system per ISO 13485, risk management per ISO 14971, software lifecycle per IEC 62304, clinical evaluation per MEDDEV 2.7/1, and a CE marking process involving a Notified Body (like TÜV or BSI). We build the technical infrastructure and documentation in parallel with the software development — not as an afterthought. Technical approach for radiology AI: (1) Data pipeline: DICOM images from the hospital PACS (Picture Archiving and Communication System) are anonymized and processed through our training pipeline. We work with the clinical team to curate labeled datasets — radiologist-annotated studies with confirmed diagnoses. (2) Model architecture: depending on the imaging task, we use convolutional neural networks (for 2D imaging like mammography and X-ray), 3D CNNs or transformer architectures (for volumetric CT and MRI data), and detection/segmentation models (for localizing specific findings). (3) Clinical integration: the AI model runs as a DICOM-compatible service that integrates with the hospital's PACS and RIS (Radiology Information System). A study arrives in PACS → the AI analyzes it → results are posted back as a DICOM Structured Report or as annotations on the images → the radiologist sees the AI findings alongside the study during their normal reading workflow. No separate platform or additional clicks required. For digital pathology: whole slide images (WSI) from digital scanners (Hamamatsu, Leica Aperio, 3DHISTECH) are processed by tissue-specific AI models. Pathology AI can: detect and grade tumors (breast cancer grading, prostate Gleason scoring), count mitotic figures, identify lymph node metastases, and quantify biomarker expression (Ki-67, PD-L1) — tasks that are tedious, time-consuming, and subject to inter-observer variability when done manually.
Healthcare / Radiology
A German breast cancer screening unit serving 280,000 women annually per the national mammography screening program (MSP) struggled with radiologist capacity. The MSP requires double reading: every mammogram must be independently reviewed by two certified screening radiologists. With 280,000 studies per year (1,120,000 individual mammographic images), the unit needed the equivalent of 8 full-time radiologists for screening reads alone. Only 5 were available — a 37% capacity shortfall that resulted in reading backlogs, extended result turnaround times (target: 7 working days; actual: 14-18 working days), and radiologist burnout. Recruiting additional screening radiologists was challenging: the certification process is lengthy, and the work (reading hundreds of normal mammograms to find the 5-8 per 1,000 that contain cancer) is mentally demanding.
We developed a mammography AI system to serve as an independent second reader, replacing one of the two required human reads. The AI model was trained on 180,000 mammographic examinations from the screening program (with outcomes: biopsy results, interval cancer data, and multi-year follow-up confirming true negatives). The model analyzes each mammographic view (CC and MLO for each breast), generates a suspicion score (0-100), and marks regions of interest on the images. Clinical workflow: (1) Mammogram acquired → sent to PACS. (2) AI analyzes the study → generates structured report with suspicion score and annotated findings. (3) First human radiologist reads the study independently. (4) AI result serves as the second read. (5) If both the human radiologist and AI agree the study is normal → normal result issued. (6) If either the human radiologist or AI flags a suspicious finding → the study goes to consensus review (a third senior radiologist reviews with both the human and AI findings). This maintains the safety net of double reading while requiring only one human read per study instead of two.
Cancer detection rate improved from 5.8 per 1,000 to 6.4 per 1,000 screened women (the AI detected cancers that the original human second reader would have missed — primarily small, subtle cancers in dense breast tissue). False positive recall rate decreased from 4.8% to 3.9% (the AI is more specific than an average human second reader on normal tissue patterns). Result turnaround time returned to target: 5-7 working days (from 14-18). The 5 available radiologists now cover the full screening volume — eliminating the need to recruit 3 additional radiologists (saving approximately €750,000 annually in recruitment and salary costs). The system received CE Class IIa marking after clinical validation and is compliant with the MSP's quality assurance requirements.
Real-time detection, classification, and counting of objects in images and video streams.
Extract structured data from documents, invoices, receipts, and forms with high accuracy.
Automated visual inspection for manufacturing defect detection with sub-second processing.
Real-time video stream analysis for surveillance, traffic monitoring, and retail analytics.
Train domain-specific models on your data using YOLO, Detectron2, SAM, and custom architectures.
Deploy vision models on edge devices (Jetson, Coral), mobile, or cloud with optimized inference.
Berlin's medical imaging AI market is competitive and innovation-dense. Mammography AI: Vara (Berlin), Lunit (Korea), Therapixel (France), and iCAD (US) all offer FDA/CE-cleared mammography AI. Radiology AI platforms: Milvue (France), Aidoc (Israel — focused on triage), and Gleamer (France). Digital pathology AI: Aignostics (Berlin), PathAI (US), Paige (US — recently CE-marked for prostate pathology). Large tech: Google Health, Microsoft Nuance (PowerScribe with AI), and Siemens Healthineers (AI-Rad Companion). The market is moving rapidly — but opportunities remain in specific imaging niches, country-specific clinical workflows, and integration with specific hospital IT ecosystems. ZTABS builds custom medical imaging AI for clinical needs not addressed by existing commercial products, and provides the MDR-compliant development pathway that smaller clinical teams cannot resource internally.
Medical imaging AI projects in Berlin range from €80,000 for single-indication proof-of-concept models (e.g., one pathology finding type) to €400,000+ for CE-marked clinical AI products with full MDR documentation and PACS integration. CE marking process (Notified Body fees, clinical validation study costs): typically €50,000-150,000 additional. Monthly hosting and maintenance for clinical AI: €3,000-8,000. The mammography AI replaced 3 radiologist positions (€750,000/year) and improved cancer detection — a return that is both financial and measured in lives.
Verified reviews from real client engagements — sourced from our public testimonial archive and Clutch profile.
My experience is throughout positive. Communication, service, the short response times and the flawless execution of a challenging topic was absolutely great. ZTABS is definitely my first choice again.
Christian Neff
Bank Software Advisory · Bank Software Advisory
Fintech
Fantastic Agency! I couldn't fault them even if I tried. They always go above and beyond to meet your expectations and always produces quality work. Thank you ZTABS.
Stephanie Kal
CEO · Beauty Finder Australia
Marketplace
It has been great working with ZTABS. They bounce off the ideas along the way. Amazing Experience.
Joel Rowe
CEO · Drill Quoter
Marketplace
We don't just contract — we ship and operate our own software. 17 products in production.
Common questions about computer vision development for Berlin businesses
Yes, and several products already have. The pathway for diagnostic AI is typically Class IIa (if the AI provides diagnostic information that a clinician interprets) or Class IIb (if the AI drives treatment decisions directly). Class IIa requires a Notified Body audit, ISO 13485 quality management, ISO 14971 risk management, IEC 62304 software lifecycle documentation, and clinical evaluation demonstrating safety and performance. We build all MDR documentation in parallel with the software development — not as a post-development exercise.
ZTABS is a remote-first computer vision development agency serving Houston businesses — including object detection & classification, document processing & ocr, quality inspection systems. We work with Energy & Oil/Gas, Healthcare & Biotech, Aerospace & Defense companies in Houston, TX via timezone-aligned engineers and async workflows; we do not have a local office, and we are explicit about that with every client.
Computer Vision Development in New York, NYZTABS is a remote-first computer vision development agency serving New York businesses — including object detection & classification, document processing & ocr, quality inspection systems. We work with Finance & Fintech, Media & Advertising, Fashion & Retail companies in New York, NY via timezone-aligned engineers and async workflows; we do not have a local office, and we are explicit about that with every client.
Computer Vision Development in Los Angeles, CAZTABS is a remote-first computer vision development agency serving Los Angeles businesses — including object detection & classification, document processing & ocr, quality inspection systems. We work with Entertainment & Media, E-commerce & DTC Brands, Gaming & AR/VR companies in Los Angeles, CA via timezone-aligned engineers and async workflows; we do not have a local office, and we are explicit about that with every client.
Web Development in Berlin, GermanyZTABS is a remote-first web development agency serving Berlin businesses — including full-stack development, progressive web apps, api development. We work with FinTech, E-commerce, Mobility companies in Berlin, Germany via timezone-aligned engineers and async workflows; we do not have a local office, and we are explicit about that with every client.
Web Design in Berlin, GermanyZTABS is a remote-first web design agency serving Berlin businesses — including ui/ux design, responsive design, custom interfaces. We work with FinTech, E-commerce, Mobility companies in Berlin, Germany via timezone-aligned engineers and async workflows; we do not have a local office, and we are explicit about that with every client.
AI Development in Berlin, GermanyZTABS is a remote-first AI development agency serving Berlin businesses — including llm integration & fine-tuning, ai agents & automation, rag & knowledge systems. We work with FinTech, E-commerce, Mobility companies in Berlin, Germany via timezone-aligned engineers and async workflows; we do not have a local office, and we are explicit about that with every client.
Computer Vision DevelopmentLearn more about our computer vision development services nationwide.
Partner with ZTABS for expert computer vision development in Berlin. Get a free consultation today.
